Trending Share

Lord’s Mark Industries Unlisted Share

169.8K

BUY

₹ 62.50

SELL

₹ 69.00

[ninja_table_cell id='6753' row="3" column="1"]

As on May 30, 2026, we are buying shares of the LORD'S MARK INDUSTRIES LIMITED for ₹ 62.50 and selling them for ₹ 69.00 per share.

About Lord’s Mark Industries Unlisted Share

Lords Mark Group, established in 1998 as a paper business, has evolved into a diversified conglomerate. Today, the group focuses on high-growth sectors—primarily In-Vitro Diagnostics (IVD), MedTech, and Renewable Energy.

With a strategic shift away from legacy businesses, Lords is actively divesting its paper division and planning a reverse merger to enter the listed space, signaling aggressive expansion and transformation.

Business Divisions

a) IVD / MedTech Division

Focused on rapid diagnostics and non-communicable disease management
Portfolio includes 34+ rapid test kits, surgical consumables, and biochemicals
Expanding into genome testing and B2C with E-smart clinics

b) Renewable Energy / LED Division

Market leader in rooftop solar installations in UP and Bihar
Strategic partnerships with Philips and defense projects
500 MW solar project target over 7 years; current order book: ₹2,000+ Cr

c) Paper Division (To Be Divested)

Currently contributes 18% of revenue
Planned divestment to focus on high-growth MedTech and solar verticals

Financial Highlights (FY22–FY24)

1. Revenue Growth:
Revenue surged from ₹213 Cr (FY22) to ₹555 Cr (FY24), indicating a CAGR of 28%.

2. Profitability Metrics:
EBITDA improved from ₹13.1 Cr to ₹38 Cr with a CAGR of 62%, while PAT rose from ₹4.2 Cr to ₹11.3 Cr (CAGR 93%).

3. Margin Expansion:
Gross margins increased from 8.92% to 13.33%, and OPM remained stable above 6%, reflecting operational efficiencies.

4. EPS Movement:
EPS stood at ₹1.01 in FY24, rising from ₹0.82 in FY23, despite equity dilution.

5. Strong Asset Base:
Total assets grew from ₹220 Cr to ₹357 Cr, with fixed assets rising from ₹18.8 Cr to ₹47 Cr.

6. Borrowings & Leverage:
Borrowings increased from ₹123 Cr (FY22) to ₹216 Cr (FY24), funding aggressive expansion.

7. Capital Structure:
Share capital expanded from ₹5 Cr to ₹56.2 Cr, while reserves reached ₹32.6 Cr, indicating equity infusions to support growth.

Pros

High CAGR in PAT and EBITDA, reflecting strong profitability momentum
Robust Order Book (₹2,000+ Cr) across solar and healthcare segments
Strategic Industry Shift towards IVD/MedTech and Renewable Energy sectors

Cons

Rising Finance Costs from ₹6 Cr to ₹18.2 Cr, impacting net margins
High Debt Levels due to expansion-led borrowings
Equity Dilution from ₹5 Cr to ₹56.2 Cr may affect existing shareholder value

Key Details

INE0MPL01010

Field	Value
Company Name
CIN
ISIN
Status
Company Type
Category
Paid Up Capital	-

Financials

No Data

Promoters or Management

Annual Reports

[ninja_tables id=”5232″]

DRHP

Powered by our people

Manya

Riya

Sujal

Frequently Asked Questions

Hindustan Media Ventures invested in Lord’s Mark shares by investing 31.22 crores to acquire share in it. This investment was made in the Lord’s Mark for the purpose of capital return in future with an aim to leverage media assets owned by the Company.

Lord’s Mark Industries, an unlisted company with a presence in diagnostics, medtech, and renewable energy, is gearing up for a big move. The company is planning to go public through a reverse merger, and if all goes according to plan, it expects to be listed on the Bombay Stock Exchange (BSE) within the next 90 to 120 days. They’ve already cleared a major hurdle by getting SEBI’s approval for the process.